Snow falling across much of Minnesota, including the Twin Cities.

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

Tuesday, the FDA’s advisory panel met to review the data and evidence of Pfizer’s COVID-19 vaccine for 5- to 11-year-olds. It’s widely expected the panel will authorize the vaccine for emergency use. Late last week, scientists at the FDA said the 

benefits far outweigh the potential risks

To talk more about the anticipated decision and what it means, Minnesota Now host Cathy Wurzer was joined by Dr. Nathan Chomilo, a pediatrician at Park Nicollet Brookdale, Senior Equity Advisor to the Commissioner of the Minnesota Department of Health and a board member for the Minnesota chapter of the American Academy of Pediatrics.

Host

Author

Are COVID-19 vaccines for kids ages 5-11 almost here? Dr. Nathan Chomilo talked to host Cathy Wurzer about what the FDA advisory panel discussed on Tuesday — and what he believes will happen next.

A group of FDA advisers were meeting Tuesday to review data on the safety and effectiveness of the Pfizer vaccine for children ages 5 through 11. 

To talk more about the anticipated decision and what it means, host Cathy Wurzer talked to Dr. Nathan Chomilo, a pediatrician at Park Nicollet Brookdale and senior equity adviser to the Commissioner of the Minnesota Department of Health. 

If the FDA green lights COVID vaccines for kids, what happens next?

Go Deeper.

Like this?

Turn Up Your Support